Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Driver gene KRAS aggravates cancer-associated stroke outcomes.

Thrombosis research - 1 Jan 2024

Yan Haomin, Sasaki Tsutomu, Gon Yasufumi, Nishiyama Kumiko, Kanki Hideaki, Mochizuki Hideki

Abstract excerpt

The incidence of cancer-associated stroke has increased with the prolonged survival times of cancer patients. Recent genetic studies have led to progress in cancer therapeutics, but relationships between oncogenic mutations and stroke remain elusive. Here, we focused on the driver gene KRAS, which is the predominant RAS isoform mutated in multiple cancer types, in cancer associated stroke study. KRASG13D/- and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to HCT116 Cells
Share to Ischemic Stroke

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins p21(ras)

Share to Stroke

Source

Identifiers

PMID: 38029547
DOI: 10.1016/j.thromres.2023.11.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Driver gene KRAS aggravates cancer-associated stroke outcomes.PMID 38029547Read ↗

Endothelial oncogenic KRAS mutation drives the dynamics of microglia and macrophages in brain arteriovenous malformation.Semantic proximity Read ↗

Stroke in adults with primary intracranial tumoursSemantic proximity Read ↗

Advances in the Study of KRAS in Brain Arteriovenous Malformation.Semantic proximity Read ↗

Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.Semantic proximity Read ↗

CRISPR/CasRx suppresses KRAS-induced brain arteriovenous malformation developed in postnatal brain endothelial cells in mice.Semantic proximity Read ↗

Selective Endothelial Hyperactivation of Oncogenic KRAS Induces Brain Arteriovenous Malformations in Mice.Semantic proximity Read ↗

MEK signaling represents a viable therapeutic vulnerability of <i>KRAS</i> -driven somatic brain arteriovenous malformationsSemantic proximity Read ↗

Mutant KRAS in brain endothelial cells promotes vascular inflammation and impairs vascular integrity in brain arteriovenous malformation.Semantic proximity Read ↗

Impact of CYP2C19 Genotype Variants on PCSK9 Inhibitor Efficacy in Lipid-Lowering Among Patients With Symptomatic Intracranial Atherosclerotic Stenosis.Semantic proximity Read ↗

Dual MAPK/VEGF inhibition for KRAS-mutated brain arteriovenous malformations.Semantic proximity Read ↗

Stroke as Initial Manifestation of Non-Small Cell Lung Cancer with Trousseau SyndromeSemantic proximity Read ↗

Stroke as initial manifestation of non-small cell lung cancer with Trousseau syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.